These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24909847)

  • 41. Hemifacial angioedema following alteplase for acute stroke.
    Clarke JD; Ayala JP
    Pract Neurol; 2019 Jun; 19(3):272-273. PubMed ID: 30837301
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemi orolingual angioedema after tPA administration for acute ischemic stroke.
    Madden B; Chebl RB
    West J Emerg Med; 2015 Jan; 16(1):175-7. PubMed ID: 25671036
    [No Abstract]   [Full Text] [Related]  

  • 43. Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase-induced orolingual angioedema.
    Theodorou A; Dimitriadou EM; Tzanetakos D; Bakola E; Chondrogianni M; Palaiodimou L; Keramida A; Vassilopoulou S; Makris M; Paraskevas GP; Tsivgoulis G
    Eur J Neurol; 2024 Apr; 31(4):e16173. PubMed ID: 38155474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ipsilateral orolingual angioedema following rhTNK-tPA administration for acute ischemic stroke.
    Shi G; Lv J; Wu W; Zhou R
    Am J Emerg Med; 2024 Mar; 77():231.e1-231.e3. PubMed ID: 38272772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurological picture. Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker.
    Tan CH; Tang SC; Lin RJ; Jeng JS
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1079. PubMed ID: 20547619
    [No Abstract]   [Full Text] [Related]  

  • 47. Anaphylactoid reaction to recombinant tissue plasminogen activator.
    Krmpotic KR; Fernandes CM
    Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolated Tongue Angioedema after Alteplase Infusion in Acute Ischemic Stroke.
    Pisani E; Gaudiano C; Petrone A; Stancati F; Siniscalchi A
    Curr Drug Saf; 2022; 17(1):75-77. PubMed ID: 34323196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
    Hill MD; Barber PA; Takahashi J; Demchuk AM; Feasby TE; Buchan AM
    CMAJ; 2000 May; 162(9):1281-4. PubMed ID: 10813008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastrointestinal Angioedema as a Side Effect of Alteplase for Acute Stroke.
    Yakhkind A; Lang AE; Montalvo M; Beland MD; Cutting S
    J Vasc Interv Radiol; 2020 Nov; 31(11):1921-1924. PubMed ID: 32636132
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of alteplase-induced orolingual angioedema by means of icatibant].
    Mas-Serrano M; Garcia-Pastor A; Tornero-Molina P; Vazquez-Alen P; Palacios-Mendoza MA; Gil-Nunez AC
    Rev Neurol; 2019 Sep; 69(6):261-262. PubMed ID: 31497871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.
    Nathaniel TI; Cochran T; Chaves J; Fulmer E; Sosa C; Yi S; Fredwall M; Sternberg S; Blackhurst D; Nelson A; Leacock R
    Brain Inj; 2016; 30(10):1261-5. PubMed ID: 27484159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
    Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.